Management of Newer Antidepressant Medications in U.S. Commercial Health Plans. [electronic resource]
Producer: 20160223Description: 165-73 p. digitalISSN:- 1091-4358
- Antidepressive Agents -- economics
- Citalopram -- economics
- Cost Control -- economics
- Cost Sharing -- economics
- Desvenlafaxine Succinate -- economics
- Drug Costs -- statistics & numerical data
- Drug Utilization
- Duloxetine Hydrochloride -- economics
- Fluvoxamine -- economics
- For-Profit Insurance Plans -- economics
- Health Care Surveys
- Health Services Accessibility -- economics
- Humans
- Insurance Coverage -- economics
- Insurance, Pharmaceutical Services -- economics
- Preferred Provider Organizations -- economics
- Private Sector -- economics
- Selegiline -- economics
- United States
- Venlafaxine Hydrochloride -- economics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.